Publication | Open Access
Tofacitinib Halts Progression of Graft Dysfunction in a Rat Model of Mixed Cellular and Humoral Rejection
17
Citations
30
References
2018
Year
Tofacitinib is able to reduce the immune response generated in a rat model of kidney graft rejection, providing prolonged graft and recipient survival, better graft function, and less histological lesions.
| Year | Citations | |
|---|---|---|
Page 1
Page 1